Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01473680 · ClinicalTrials.gov registry record
Neuropsychologic and Electrophysiological Features of Cancer-Related Cognitive Side Effects in Racial and Ethnic Minority Breast Cancer Patients
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Terminated
- Registry status
- 2
- Enrollment target
NCT01473680: Clinical Trial study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT01473680 is a clinical trial that was terminated before completion, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01473680 was terminated before completion, sponsored by Memorial Sloan Kettering Cancer Center.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
This study is being done to find out if it is possible to enroll minority women with breast cancer in a study of how chemotherapy may affect their ability to answer certain questions and perform certain tasks that measure brain activity. The investigators want to look at thinking and brain activity in patients to see if cancer treatments can cause any brain changes. For this study, women without cancer, are being asked to participate in order to compare the answers to the questions and the brain wave activity measured in the women with cancer to women who don't have cancer.
Primary Outcome
through administration of NP and psychological instruments and EEG
Interventions
- OTHER EEG, Neuropsychological Evaluation, Psychological Questionnaires, Medical Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2011-11 |
| Est. Completion | 2012-09 |
Why NCT01473680 stopped before completion
NCT01473680 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which EEG, Neuropsychological Evaluation, Psychological Questionnaires, Medical Questionnaire is the first listed.
NCT01473680 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01473680 about?
NCT01473680 is a clinical study titled "Neuropsychologic and Electrophysiological Features of Cancer-Related Cognitive Side Effects in Racial and Ethnic Minority Breast Cancer Patients". This study is being done to find out if it is possible to enroll minority women with breast cancer in a study of how chemotherapy may affect their ability to answer certain questions and perform certain tasks that measure brain activity. The investigators want to look at thinking and brain activity ...
What is the current status of trial NCT01473680?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2011-11. Estimated completion is 2012-09.
What interventions are being tested in trial NCT01473680?
The interventions under investigation include: EEG, Neuropsychological Evaluation, Psychological Questionnaires, Medical Questionnaire (OTHER).
Who is sponsoring clinical trial NCT01473680?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia